Product Information

FENOFIBRATE 160 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1129 per EA under NDC 27241011705. Its NADAC has been published 287 times since Feb 24, 2021.

FDA first approved this application on Jul 23, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

FENOFIBRATE 160 MG TABLET

fenofibrate
$0.1129per EA

Strength

160 mg/1

NDC

27241011705

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

FENOFIBRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA210138

FDA Approved

7/23/2018

TE Code

AB

On Market Since

7/20/2018

Price Statistics

The NADAC for FENOFIBRATE 160 MG TABLET has been published 287 times since Feb 24, 2021, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1129 per EA
All-time high$0.2802 (May 12, 2021)
All-time low$0.0892 (Dec 17, 2025)
52-week high$0.1259
52-week low$0.0892
Median price$0.1340
Average price$0.1512
Largest weekly change+41.1% (Jan 17, 2024)
Weeks tracked287
Tracking sinceFeb 24, 2021

Price History

1W

+0.9%

1M

+0.9%

3M

-8.9%

6M

+11.9%

1Y

-10.1%

3Y

-31.9%

5Y

-48.2%

All

-52.4%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of FENOFIBRATE 160 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.1129 per EA (NDC 27241011705), effective Aug 19, 2026.

How has the price of FENOFIBRATE 160 MG TABLET changed over time?

Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has declined 52.4%. It has been tracked across 287 weekly CMS publications since Feb 24, 2021.

What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?

Since Feb 24, 2021, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0892 (Dec 17, 2025) to a high of $0.2802 (May 12, 2021), with a median of $0.1340 per EA.

Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 160 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures FENOFIBRATE 160 MG TABLET?

FENOFIBRATE 160 MG TABLET (NDC 27241011705) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.